{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:34:50Z","timestamp":1756996490973,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-022-05217-x","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T10:03:01Z","timestamp":1664013781000},"page":"545-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Giant cell arteritis successfully treated with subcutaneous tocilizumab monotherapy"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8712-3852","authenticated-orcid":false,"given":"Misako","family":"Higashida-Konishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5075-8977","authenticated-orcid":false,"given":"Mitsuhiro","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Oshige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-0759","authenticated-orcid":false,"given":"Keisuke","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-5907","authenticated-orcid":false,"given":"Hisaji","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1373-8840","authenticated-orcid":false,"given":"Yutaka","family":"Okano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,24]]},"reference":[{"key":"5217_CR1","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1093\/rheumatology\/kex424","volume":"57","author":"MJ Koster","year":"2018","unstructured":"Koster MJ, Matteson EL, Warrington KJ (2018) Large-vessel giant cell arteritis: diagnosis, monitoring and management. Rheumatology (Oxford) 57:ii32\u2013ii42. https:\/\/doi.org\/10.1093\/rheumatology\/kex424","journal-title":"Rheumatology (Oxford)"},{"key":"5217_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2019.02.007","volume":"206","author":"CM Weyand","year":"2019","unstructured":"Weyand CM, Watanabe R, Zhang H, Akiyama M, Berry GJ, Goronzy JJ (2019) Cytokines, growth factors and proteases in medium and large vessel vasculitis. Clin Immunol 206:33\u201341. https:\/\/doi.org\/10.1016\/j.clim.2019.02.007","journal-title":"Clin Immunol"},{"key":"5217_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.621098","volume":"11","author":"M Akiyama","year":"2021","unstructured":"Akiyama M, Ohtsuki S, Berry GJ, Liang DH, Goronzy JJ, Weyand CM (2021) Innate and adaptive immunity in giant cell arteritis. Front Immunol 11:621098. https:\/\/doi.org\/10.3389\/fimmu.2020.621098","journal-title":"Front Immunol"},{"key":"5217_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/imj.12293","volume":"44","author":"E Dunstan","year":"2014","unstructured":"Dunstan E, Lester SL, Rischmueller M, Dodd T, Black R, Ahern M et al (2014) Epidemiology of biopsy-proven giant cell arteritis in South Australia. Intern Med J 44:32\u201339. https:\/\/doi.org\/10.1111\/imj.12293","journal-title":"Intern Med J"},{"key":"5217_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","volume":"377","author":"JH Stone","year":"2017","unstructured":"Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D et al (2017) Trial of tocilizumab in giant-cell arteritis. N Engl J Med 377:317\u2013328. https:\/\/doi.org\/10.1056\/NEJMoa1613849","journal-title":"N Engl J Med"},{"key":"5217_CR6","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/rheumatology\/kez511","volume":"59","author":"S Saito","year":"2020","unstructured":"Saito S, Okuyama A, Okada Y, Shibata A, Sakai R, Kurasawa T et al (2020) Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study. Rheumatology (Oxford) 59:1617\u20131621. https:\/\/doi.org\/10.1093\/rheumatology\/kez511","journal-title":"Rheumatology (Oxford)"},{"key":"5217_CR7","volume":"141","author":"M Seitz","year":"2011","unstructured":"Seitz M, Reichenbach S, Bonel HM, Adler S, Wermelinger F, Villiger PM (2011) Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly 141:w13156","journal-title":"Swiss Med Wkly"},{"key":"5217_CR8","first-page":"S59","volume":"31","author":"G Pazzola","year":"2013","unstructured":"Pazzola G, Padovano I, Boiardi L, Versari A, Pipitone N, Catanoso M et al (2013) Tocilizumab in glucocorticoid-na\u00efve large-vessel vasculitis. Clin Exp Rheumatol 31:S59-61","journal-title":"Clin Exp Rheumatol"},{"key":"5217_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"5217_CR10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/art.40379","volume":"70","author":"PC Grayson","year":"2018","unstructured":"Grayson PC, Alehashemi S, Bagheri AA, Civelek AC, Cupps TR, Kaplan MJ et al (2018) 18 F-Fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthr Rheumatol 70:439\u2013449. https:\/\/doi.org\/10.1002\/art.40379","journal-title":"Arthr Rheumatol"},{"key":"5217_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C et al (2012) 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71:484\u2013492. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200329","journal-title":"Ann Rheum Dis"},{"key":"5217_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001652","volume":"8","author":"M Sandovici","year":"2022","unstructured":"Sandovici M, Geest NVD, Sleen YV, Brouwer E (2022) Need and value of targeted immunosuppressive therapy in giant cell arteritis. RMD Open 8:e001652. https:\/\/doi.org\/10.1136\/rmdopen-2021-001652","journal-title":"RMD Open"},{"key":"5217_CR13","first-page":"98","volume":"37","author":"N Pipitone","year":"2019","unstructured":"Pipitone N, Muratore F, Tamagnini I, Cavazza A, Cimino L, Boiardi L et al (2019) Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritis. Clin Exp Rheumatol 37:98\u2013103","journal-title":"Clin Exp Rheumatol"},{"key":"5217_CR14","first-page":"122","volume":"37","author":"C Grossman","year":"2019","unstructured":"Grossman C, Yassin N, Avivi C, Bornstein G, Ben-Zvi I, Barshack I (2019) Cytokine expression in temporal arteries: comparative analysis between patients with biopsy-positive giant cell arteritis, biopsy-negative giant cell arteritis and biopsy-negative without arteritis. Clin Exp Rheumatol 37:122\u2013129","journal-title":"Clin Exp Rheumatol"},{"key":"5217_CR15","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2018-214704","volume":"78","author":"CT Berger","year":"2019","unstructured":"Berger CT, Rebholz-Chaves B, Recher M, Manigold T, Daikeler T (2019) Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses. Ann Rheum Dis 78:1012\u20131014. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214704","journal-title":"Ann Rheum Dis"},{"key":"5217_CR16","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1093\/rheumatology\/keaa894","volume":"60","author":"KA Quinn","year":"2021","unstructured":"Quinn KA, Dashora H, Novakovich E, Ahlman MA, Grayson PC (2021) Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis. Rheumatology (Oxford) 60:4384\u20134389. https:\/\/doi.org\/10.1093\/rheumatology\/keaa894","journal-title":"Rheumatology (Oxford)"},{"key":"5217_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s40674-019-00114-0","volume":"5","author":"KA Quinn","year":"2019","unstructured":"Quinn KA, Grayson PC (2019) The role of vascular imaging to advance clinical care and research in large-vessel vasculitis. Curr Treatm Opt Rheumatol 5:20\u201335. https:\/\/doi.org\/10.1007\/s40674-019-00114-0","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"5217_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.semarthrit.2019.12.005","volume":"50","author":"M Akiyama","year":"2020","unstructured":"Akiyama M, Kaneko Y, Takeuchi T (2020) Tocilizumab in isolated polymyalgia rheumatica: a systematic literature review. Semin Arthr Rheum 50:521\u2013525. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.12.005","journal-title":"Semin Arthr Rheum"},{"key":"5217_CR19","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.semarthrit.2020.07.001","volume":"50","author":"M Akiyama","year":"2020","unstructured":"Akiyama M, Kaneko Y, Takeuchi T (2020) Response to a letter to the editor entitled \u201cis tocilizumab as efficient as steroids early in polymyalgia rheumatica?\u201d Semin Arthr Rheum 50:890. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.07.001","journal-title":"Semin Arthr Rheum"},{"key":"5217_CR20","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/rheumatology\/kez091","volume":"58","author":"S Adler","year":"2019","unstructured":"Adler S, Reichenbach S, Gloor A, Yerly D, Cullmann JL, Villiger PM (2019) Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis. Rheumatology 58:1639\u20131643. https:\/\/doi.org\/10.1093\/rheumatology\/kez091","journal-title":"Rheumatology"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05217-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05217-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05217-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T08:05:26Z","timestamp":1677312326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05217-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["5217"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05217-x","relation":{},"ISSN":["1437-160X"],"issn-type":[{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2022,9,24]]},"assertion":[{"value":"23 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interest related to this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for publication of this report was obtained from the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}